Dechtman Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Dechtman Wealth Management, LLC

  • $447 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
BUY
$47.98 - $54.4 $1,967 - $2,230
41 Added 0.99%
4,201 $227,000
Q4 2023

Jan 19, 2024
BUY
$48.48 - $57.85 $1,793 - $2,140
37 Added 0.9%
4,160 $213,000
Q3 2023

Oct 16, 2023
SELL
$57.89 - $64.73 $341,551 - $381,907
-5,900 Reduced 58.86%
4,123 $239,000
Q2 2023

Sep 08, 2023
BUY
$63.71 - $70.74 $638,565 - $709,027
10,023 New
10,023 $641 Million

Others Institutions Holding BMY

# of Institutions
2,425
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dechtman Wealth Management, LLC Portfolio

Follow Dechtman Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dechtman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dechtman Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email